Walk away from memory loss: exercise trial for kidney patients

NCT ID NCT07160959

Not yet recruiting Prevention Sponsor: Biogem s.c.ar.l. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a simple home exercise program can prevent memory and thinking problems from getting worse in people with advanced chronic kidney disease (stages 4-5). 124 participants will either do low-intensity walking and strength exercises or receive standard care. The goal is to find an easy, drug-free way to protect brain health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: home-based low-intensity interval exercise program (walking and strength training)
What this could lead to: If it works, this could offer a simple, drug-free way to protect brain function in people with advanced kidney disease.
What could go wrong: This is a small, early-stage trial (124 people) testing a behavioral intervention, so results may not be generalizable. Exercise adherence at home may be low, and cognitive benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (STAGES 4 AND 5) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome Cognitive Dysfunction end stage renal failure Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE (STAGES 4 AND 5) MILD COGNITIVE IMPAIRMENT (MCI)

Contacts and locations

Locations

Assistance Publique - Hôpitaux de Paris (AP-HP), Division of Geriatry

Paris, France
Biogem

Ariano Irpino, 83031, Italy
Lithuanian University of Health Sciences

Kaunas, Lithuania
Medical University of Warsaw, Department of Nephrology, Dialysis and Internal Medicine

Warsaw, Poland
University Medical Center Groningen, Department of Nephrology

Groningen, Netherlands
University of Zurich

Zurich, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.